{"title":"不同方法治疗肉芽肿性小叶性乳腺炎的临床疗效:系统综述和网络荟萃分析。","authors":"Yuxiang Zhou, Leilai Xu","doi":"10.1371/journal.pone.0318236","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This network meta-analysis aims to evaluate the recurrence rates of various treatment options for granulomatous lobular mastitis.</p><p><strong>Methods: </strong>We systematically searched and identified eligible studies in PubMed, EMBASE, Cochrane Library, and Web of Science databases until September 30, 2023. Original studies reporting the recurrence rates of various treatments were included. Subsequently, literature screening, data extraction, and network meta-analysis were conducted. This study was registered with PROSPERO (registration number CRD 42023434773).</p><p><strong>Results: </strong>Nineteen articles involving 1,095 patients were included in this study. The network meta-analysis revealed that several treatment combinations reduced the recurrence rate compared to observation: Surgery + Local steroid injection + Systemic steroids therapy (OR: 0.23, 95% CI 0.01 to 4.53), Local steroid injection (OR: 0.34, 95% CI 0.02 to 6.81), Surgery + Systemic steroids therapy (OR: 0.36, 95% CI 0.02 to 5.29), Surgery + Traditional Chinese Medicine (OR: 0.33, 95% CI 0.01 to 9.11), Systemic steroids therapy + MTX (OR: 0.62, 95% CI 0.01 to 34.59), and Systemic steroids therapy + drainage (OR: 0.76, 95% CI 0.05 to 10.67). Among these, Surgery + Local steroid injection + Systemic steroids therapy demonstrated superior efficacy. The surface under cumulative ranking curve (SUCRA) values were highest for Surgery + Local steroid injection + Systemic steroids therapy (0.85), followed by Local steroid injection (0.78) and Surgery + Systemic steroids therapy (0.77).</p><p><strong>Conclusions: </strong>Steroid-based combination therapy may be the first choice for IGM patients, with a comprehensive strategy of local and systemic steroids combined with surgery having the best effect on IGM.</p>","PeriodicalId":20189,"journal":{"name":"PLoS ONE","volume":"20 2","pages":"e0318236"},"PeriodicalIF":2.6000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11790104/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical efficacy of different methods for treatment of granulomatous lobular mastitis: A systematic review and network meta-analysis.\",\"authors\":\"Yuxiang Zhou, Leilai Xu\",\"doi\":\"10.1371/journal.pone.0318236\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This network meta-analysis aims to evaluate the recurrence rates of various treatment options for granulomatous lobular mastitis.</p><p><strong>Methods: </strong>We systematically searched and identified eligible studies in PubMed, EMBASE, Cochrane Library, and Web of Science databases until September 30, 2023. Original studies reporting the recurrence rates of various treatments were included. Subsequently, literature screening, data extraction, and network meta-analysis were conducted. This study was registered with PROSPERO (registration number CRD 42023434773).</p><p><strong>Results: </strong>Nineteen articles involving 1,095 patients were included in this study. The network meta-analysis revealed that several treatment combinations reduced the recurrence rate compared to observation: Surgery + Local steroid injection + Systemic steroids therapy (OR: 0.23, 95% CI 0.01 to 4.53), Local steroid injection (OR: 0.34, 95% CI 0.02 to 6.81), Surgery + Systemic steroids therapy (OR: 0.36, 95% CI 0.02 to 5.29), Surgery + Traditional Chinese Medicine (OR: 0.33, 95% CI 0.01 to 9.11), Systemic steroids therapy + MTX (OR: 0.62, 95% CI 0.01 to 34.59), and Systemic steroids therapy + drainage (OR: 0.76, 95% CI 0.05 to 10.67). Among these, Surgery + Local steroid injection + Systemic steroids therapy demonstrated superior efficacy. The surface under cumulative ranking curve (SUCRA) values were highest for Surgery + Local steroid injection + Systemic steroids therapy (0.85), followed by Local steroid injection (0.78) and Surgery + Systemic steroids therapy (0.77).</p><p><strong>Conclusions: </strong>Steroid-based combination therapy may be the first choice for IGM patients, with a comprehensive strategy of local and systemic steroids combined with surgery having the best effect on IGM.</p>\",\"PeriodicalId\":20189,\"journal\":{\"name\":\"PLoS ONE\",\"volume\":\"20 2\",\"pages\":\"e0318236\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-02-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11790104/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PLoS ONE\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.1371/journal.pone.0318236\",\"RegionNum\":3,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS ONE","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1371/journal.pone.0318236","RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
摘要
目的:本网络荟萃分析旨在评估肉芽肿性小叶性乳腺炎不同治疗方案的复发率。方法:我们在PubMed、EMBASE、Cochrane Library和Web of Science数据库中系统检索并确定了符合条件的研究,截止到2023年9月30日。原始研究报告了各种治疗的复发率。随后进行文献筛选、数据提取、网络meta分析。本研究已在PROSPERO注册(注册号CRD 42023434773)。结果:本研究纳入19篇文章,共1095例患者。网络荟萃分析显示,与观察相比,几种治疗组合降低了复发率:手术+局部类固醇注射+全身类固醇治疗(OR: 0.23, 95% CI 0.01至4.53),局部类固醇注射(OR: 0.34, 95% CI 0.02至6.81),手术+全身类固醇治疗(OR: 0.36, 95% CI 0.02至5.29),手术+中药(OR: 0.33, 95% CI 0.01至9.11),全身类固醇治疗+ MTX (OR:0.62, 95% CI 0.01 ~ 34.59),以及全身类固醇治疗+引流(OR: 0.76, 95% CI 0.05 ~ 10.67)。其中,手术+局部类固醇注射+全身类固醇治疗效果更佳。累积排序曲线下曲面(SUCRA)值以手术+局部类固醇注射+全身类固醇治疗最高(0.85),其次为局部类固醇注射(0.78)和手术+全身类固醇治疗(0.77)。结论:以类固醇为主的联合治疗可能是IGM患者的首选,局部和全身类固醇联合手术治疗IGM效果最好。
Clinical efficacy of different methods for treatment of granulomatous lobular mastitis: A systematic review and network meta-analysis.
Objective: This network meta-analysis aims to evaluate the recurrence rates of various treatment options for granulomatous lobular mastitis.
Methods: We systematically searched and identified eligible studies in PubMed, EMBASE, Cochrane Library, and Web of Science databases until September 30, 2023. Original studies reporting the recurrence rates of various treatments were included. Subsequently, literature screening, data extraction, and network meta-analysis were conducted. This study was registered with PROSPERO (registration number CRD 42023434773).
Results: Nineteen articles involving 1,095 patients were included in this study. The network meta-analysis revealed that several treatment combinations reduced the recurrence rate compared to observation: Surgery + Local steroid injection + Systemic steroids therapy (OR: 0.23, 95% CI 0.01 to 4.53), Local steroid injection (OR: 0.34, 95% CI 0.02 to 6.81), Surgery + Systemic steroids therapy (OR: 0.36, 95% CI 0.02 to 5.29), Surgery + Traditional Chinese Medicine (OR: 0.33, 95% CI 0.01 to 9.11), Systemic steroids therapy + MTX (OR: 0.62, 95% CI 0.01 to 34.59), and Systemic steroids therapy + drainage (OR: 0.76, 95% CI 0.05 to 10.67). Among these, Surgery + Local steroid injection + Systemic steroids therapy demonstrated superior efficacy. The surface under cumulative ranking curve (SUCRA) values were highest for Surgery + Local steroid injection + Systemic steroids therapy (0.85), followed by Local steroid injection (0.78) and Surgery + Systemic steroids therapy (0.77).
Conclusions: Steroid-based combination therapy may be the first choice for IGM patients, with a comprehensive strategy of local and systemic steroids combined with surgery having the best effect on IGM.
期刊介绍:
PLOS ONE is an international, peer-reviewed, open-access, online publication. PLOS ONE welcomes reports on primary research from any scientific discipline. It provides:
* Open-access—freely accessible online, authors retain copyright
* Fast publication times
* Peer review by expert, practicing researchers
* Post-publication tools to indicate quality and impact
* Community-based dialogue on articles
* Worldwide media coverage